ENANTA PHARMACEUTICALS INC
ENTANasdaqHealthcare · Pharmaceutical Preparations · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $65.3M | $67.6M | $79.2M | $86.2M | $97.1M | $27.6M |
| Operating income | −$85.3M | −$121.7M | −$137.2M | −$123.8M | −$109.6M | −$41.6M |
| Net income | −$81.9M | −$116.0M | −$133.8M | −$121.8M | −$79.0M | −$6.0M |
| Total assets | $280.7M | $376.7M | $462.3M | $375.4M | $438.8M | $486.1M |
| Total liabilities | $216.0M | $247.8M | $245.5M | $54.1M | $39.4M | $30.6M |
| Equity | $64.7M | $128.8M | $216.7M | $321.3M | $399.4M | $455.6M |
| EPS (diluted) | $-3.84 | $-5.48 | $-6.38 | $-5.91 | $-3.92 | $-0.30 |
| Shares out. | 28.9M | 21.2M | 21.1M | 20.8M | 20.3M | 20.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −130.7%
- Net margin
- −125.4%
- Return on equity
- −126.5%
- Return on assets
- −29.2%
- Return on capital (ROCE)
- −36.8%
- Liabilities / assets
- 76.9%
- Debt / equity
- 3.34×
- Book value / share
- $2.24
- Revenue growth (YoY)
- −3.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.79distress
- Accruals / assets
- −22.3%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 10, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Clinical trials
ClinicalTrials.gov · ongoing · next readout first- Phase 1Recruitingreadout ~2026-11A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults
- Phase 2Not Yet Recruitingreadout ~2026-12A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 26, 2026
- Deep Track Capital, LpPassive (13G)Feb 13, 2026
- Farallon Capital Partners, L.P.Passive (13G)Feb 5, 2026
- Integrated Core Strategies (Us) LlcPassive (13G)Jan 20, 2026
- Janus Henderson Group PlcPassive (13G)Nov 7, 2025
- Blackrock, Inc.Passive (13G)Apr 17, 2025
- Luly Jay R.Activist (13D)Feb 14, 2025
- Krensavage Asset Management, LlcPassive (13G)Feb 27, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.2M | 9.4 | +2.2% |
| Apr 30, 2026 | 2.2M | 18.8 | +2.6% |
| Apr 15, 2026 | 2.1M | 17.3 | -1.5% |
| Mar 31, 2026 | 2.1M | 15.5 | -1.4% |
| Mar 13, 2026 | 2.2M | 11.2 | -1.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 11, 2026
- Other material eventMar 26, 2026
- Director / officer change · Shareholder voteMar 12, 2026
- Results of operationsFeb 9, 2026
- Results of operationsNov 17, 2025
- Other material eventOct 1, 2025
- Regulation FD disclosureSep 29, 2025
- Regulation FD disclosure · Other material eventSep 29, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- S-8May 13, 2026
- 10-QMay 13, 2026
- 8-KMay 11, 2026
- SCHEDULE 13G/AMar 26, 2026
- 8-KMar 26, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 13, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 13, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 13, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 13, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 13, 2026
- 4STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIESMar 13, 2026
- 8-KMar 12, 2026
- EFFECTFeb 20, 2026
- CORRESPFeb 17, 2026
- UPLOADFeb 17, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.